UPS Healthcare Expands Global Cold Chain Logistics Network
Marken, the clinical trial logistics operation with UPS Healthcare, has expanded its global network to support increased demand for its clinical drug supply chain services, particularly for cell and gene clinical trials. Plans for the remainder of 2021 and 2022 will support accelerated demand for mRNA therapies, cell and gene therapies, early access and managed access programs. Expansion plans include new locations, expanded cold chain services and packaging solutions.
Marken's ongoing and planned investments include:
- The addition of over 100,000 square feet of GMP-compliant depot operations in Louisville, KY, Great Valley, PA, and Seoul, South Korea.
- A new GMP depot facility in Kiev, Ukraine
- A new GDP depot facility in Osaka, Japan
- New locations in Nairobi, Kenya and Accra, Ghana
- Expansion of its kit assembly facility in Shanghai, China
- New liquid nitrogen (LN2) filling stations within each of its global cell and gene centers of excellence
- Infrastructure expansion at its facilities in Belgium, France, South Africa, India, Taiwan, China, and Singapore
- Packaging and technology enhancements for real-time location tracking and temperature monitoring of cell and gene therapy shipments
This new control center, combined with the existing control center in Durham, NC, US, will support 24/7/365 global monitoring of all complex shipments, including cell and gene shipments.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
